These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Total androgen blockade in the treatment of hormone-resistant metastasized prostate carcinoma. A literature review.
    Author: Oosterlinck W, Mast P.
    Journal: Acta Urol Belg; 1994 Apr; 62(1):67-71. PubMed ID: 8197932.
    Abstract:
    Once hormone resistance has been developed in metastasized prostate cancer, the main aim of therapy is to ensure quality of life. Total androgen blockade which neutralizes the androgens of adrenal origin provides a therapeutic modality which gives +/- 16% objective and +/- 50% subjective response during several months. The two drugs actual available in Belgium are flutamide and cyproterone acetate. Especially flutamide has been used for this purpose. As the number and intensity of side effects is low, this can be considered as a first choice treatment when prostate cancer escapes its first line therapy.
    [Abstract] [Full Text] [Related] [New Search]